2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Motif Bio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 Iclaprim, Vancomycin - Skin Structures and Soft Tissue Infections | Phase 3 | Completed | Motif Bio | 613 | 2015-11-01 | 2018-08-07 |
| Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 iclaprim, vancomycin - Skin Structures and Soft Tissue Infections | Phase 3 | Completed | Motif Bio | 600 | 2015-11-01 | 2018-06-19 |
Vancomycin (2) · iclaprim (2)
United States (2) · Argentina (1) · Belgium (1) · Bulgaria (1) · Chile (1) · Colombia (1) · Croatia (1) · Czechia (1) · Estonia (1) · Germany (1) · Hungary (1) · Latvia (1) · Peru (1) · Poland (1) · Portugal (1)
David Huang, MD, PhD (1) · Stephanie Noviello, MD (1)